Aqr Capital Management LLC Affimed N.V. Transaction History
Aqr Capital Management LLC
- $58.2 Billion
- Q1 2024
Shares
10 transactions
Others Institutions Holding AFMD
# of Institutions
4Shares Held
1.1MCall Options Held
0Put Options Held
0-
Tekla Capital Management LLC586KShares$3.19 Million0.01% of portfolio
-
Act Capital Management, LLC Wayne, PA309KShares$1.68 Million0.88% of portfolio
-
Telemetry Investments, L.L.C. New York, NY200KShares$1.09 Million0.39% of portfolio
-
Ifp Advisors, Inc1.15KShares$6,2670.0% of portfolio
About Affimed N.V.
- Ticker AFMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,339,008
- Market Cap $814M
- Description
- Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...